PeptidePedia The community reference

Contract development and manufacturing organisation: difference between revisions

Diff·revision 18 → 19·04:37, 18 Jul 2025

Difference between revision 18 and revision 19 of Contract development and manufacturing organisation. 5 lines changed; the page grew by 554 bytes.

Revision 18 — 00:16, 30 Jun 2025
RepackRadek (talk)
state that a phase-change pack and a gel pack behave differently
4,240 bytes +24
Revision 19 — 04:37, 18 Jul 2025
Chromatokid (talk)
expand §Consequences for reading documentation
4,794 bytes +554
34Where a claim about in-house manufacture is made, it is checkable in principle against corporate registration and facility records — the kind of documentary review described at [[VendorInvestigate]] — and not checkable at all by analysis of the material.{{r|reports}}34Where a claim about in-house manufacture is made, it is checkable in principle against corporate registration and facility records — the kind of documentary review described at [[VendorInvestigate]] — and not checkable at all by analysis of the material.{{r|reports}}
3535
+36== Why the arrangement is unremarkable ==
+37Contract manufacture is the normal structure of the fine-chemical industry, including for approved medicines. Treating it as inherently suspicious is not supportable, and a supplier that contracts out manufacture is not thereby doing anything irregular.{{r|ich_q7}}
+38
+39What is worth attention is consistency between what is claimed and what is documented. A specific claim about a facility, a certification or a capability is a checkable claim; a general impression conveyed by photographs and adjectives is not.
+40
36== References ==41== References ==
37{{reflist}}42{{reflist}}